Atomoxetine Associated Activation Syndrome in Adolescent Patients With ADHD
- PMID: 38901013
- DOI: 10.1097/JCP.0000000000001875
Atomoxetine Associated Activation Syndrome in Adolescent Patients With ADHD
References
-
- Yu G, Li GF, Markowitz JS. Atomoxetine: a review of its pharmacokinetics and pharmacogenomics relative to drug disposition. J Child Adolesc Psychopharmacol . 2016;26:314–326.
-
- Harada T, Sakamoto K, Ishigooka J. Incidence and predictors of activation syndrome induced by antidepressants. Depress Anxiety . 2008;25:1014–1019.
-
- Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther . 1981;30:239–245.
-
- Henderson TA. Mania induction associated with atomoxetine. J Clin Psychopharmacol . 2004;24:567–568.
-
- Guney E, Uneri OS. Atomoxetine-induced hypomania-like symptoms in a preadolescent patient. J Child Adolesc Psychopharmacol . 2014;24:530–531.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical